Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Supernus Pharmaceuticals (SUPN)

Supernus Appoints Frank Mottola Chief Technical Operations Officer, Raises Pay

Neutral Impact 2 of 5 leadership Written later

Supernus Pharmaceuticals named Frank Mottola, previously its Senior Vice President, Quality, GMP Operations and IT, as Chief Technical Operations Officer effective June 16, 2025. His annual base salary rose from $392,500 to $412,500 and his 2025 bonus target rose from 35% to 40% of base salary.

Key points

  • Frank Mottola appointed Chief Technical Operations Officer, effective June 16, 2025
  • Annual base salary increased from $392,500 to $412,500
  • 2025 bonus target increased from 35% to 40% of base salary
  • Board approved the appointment and pay changes on the Compensation Committee's May 30, 2025 recommendation

The filing

CompanySupernus Pharmaceuticals (SUPN)
Form8-K, current report
Filed with the SECAug 1, 2025, 6:04 PM ET
Accession number0001356576-25-000050

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 01, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.